Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4133)	6/15/2001 7:11:59 PM
From: jj_	Read Replies (1) \| Respond to of 52153

do you have a link for hgsi -also since you brought hgsi up,where are you a buyer-I missed it at 40 during last correction(it was there for about a month)could have bought it in low 60's last 2 days, a solid entry for hgsi in this current correction-

To: Biomaven who wrote (4133)	6/15/2001 7:29:47 PM
From: nigel bates	Respond to of 52153

Incidentally, they have re-iterated their 100k (or more) human gene claim on an "apples to apples" basis OGSI announced a crack at this today. Some similarities to HGSI's approach in that they are working backwards towards the genes. Message 15948021 Oxford GlycoSciences Plc (LSE: OGS, Nasdaq: OGSI) today announces that it is building a Protein Atlas of the Human Genome that will, for the first time, use sequence information obtained directly from naturally occurring human proteins to identify unambiguously all protein-coding genes in the human genome...